<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34835130</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>10</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>11</Issue><PubDate><Year>2021</Year><Month>Nov</Month><Day>21</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Indications of Persistent Glycocalyx Damage in Convalescent COVID-19 Patients: A Prospective Multicenter Study and Hypothesis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2324</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v13112324</ELocationID><Abstract><AbstractText>The COVID-19 pandemic is caused by the SARS CoV-2 virus and can lead to severe lung damage and hyperinflammation. In the context of COVID-19 infection, inflammation-induced degradation of the glycocalyx layer in endothelial cells has been demonstrated. Syndecan-1 (SDC-1) is an established parameter for measuring glycocalyx injury. This prospective, multicenter, observational, cross-sectional study analyzed SDC-1 levels in 24 convalescent patients that had been infected with SARS-CoV-2 with mild disease course without need of hospitalization. We included 13 age-matched healthy individuals and 10 age-matched hospitalized COVID-19 patients with acute mild disease course as controls. In convalescent COVID-19 patients, significantly elevated SDC-1 levels were detected after a median of 88 days after symptom onset compared to healthy controls, whereas no difference was found when compared to SDC-1 levels of hospitalized patients undergoing acute disease. This study is the first to demonstrate signs of endothelial damage in non-pre-diseased, convalescent COVID-19 patients after mild disease progression without hospitalization. The data are consistent with studies showing evidence of persistent endothelial damage after severe or critical disease progression. Further work to investigate endothelial damage in convalescent COVID-19 patients should follow.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vollenberg</LastName><ForeName>Richard</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-3208-7924</Identifier><AffiliationInfo><Affiliation>Department of Medicine B for Gastroenterology, Hepatology, Endocrinology and Clinical Infectiology, University Hospital Muenster, 48149 Muenster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tepasse</LastName><ForeName>Phil-Robin</ForeName><Initials>PR</Initials><Identifier Source="ORCID">0000-0002-2757-4755</Identifier><AffiliationInfo><Affiliation>Department of Medicine B for Gastroenterology, Hepatology, Endocrinology and Clinical Infectiology, University Hospital Muenster, 48149 Muenster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ochs</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-3005-7190</Identifier><AffiliationInfo><Affiliation>Department of Medicine B for Gastroenterology, Hepatology, Endocrinology and Clinical Infectiology, University Hospital Muenster, 48149 Muenster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Floer</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The First Department of Medicine, Klinikum Ibbenb&#xfc;ren, 49477 Ibbenb&#xfc;ren, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strauss</LastName><ForeName>Markus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology I-Coronary and Peripheral Vascular Disease, Heart Failure Medicine, University Hospital Muenster, 48149 Muenster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rennebaum</LastName><ForeName>Florian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Medicine B for Gastroenterology, Hepatology, Endocrinology and Clinical Infectiology, University Hospital Muenster, 48149 Muenster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kabar</LastName><ForeName>Iyad</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Medicine B for Gastroenterology, Hepatology, Endocrinology and Clinical Infectiology, University Hospital Muenster, 48149 Muenster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rovas</LastName><ForeName>Alexandros</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-3866-0701</Identifier><AffiliationInfo><Affiliation>Department of Medicine D, Division of General Internal and Emergency Medicine, Nephrology, and Rheumatology, University Hospital Muenster, 48149 Muenster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nowacki</LastName><ForeName>Tobias</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-4530-5786</Identifier><AffiliationInfo><Affiliation>Department of Medicine B for Gastroenterology, Hepatology, Endocrinology and Clinical Infectiology, University Hospital Muenster, 48149 Muenster, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Gastroenterology, Marienhospital Steinfurt, 48565 Steinfurt, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C508241">SDC1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053668">Syndecan-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004730" MajorTopicYN="N">Endothelium, Vascular</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019276" MajorTopicYN="N">Glycocalyx</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053668" MajorTopicYN="N">Syndecan-1</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">glycocalyx</Keyword><Keyword MajorTopicYN="N">long-COVID-19</Keyword><Keyword MajorTopicYN="N">syndecan-1</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>10</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>27</Day><Hour>1</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>11</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34835130</ArticleId><ArticleId IdType="pmc">PMC8619155</ArticleId><ArticleId IdType="doi">10.3390/v13112324</ArticleId><ArticleId IdType="pii">v13112324</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gupta A., Madhavan M.V., Sehgal K., Nair N., Mahajan S., Sehrawat T.S., Bikdeli B., Ahluwalia N., Ausiello J.C., Wan E.Y., et al. Extrapulmonary manifestations of COVID-19. Nat. Med. 2020;26:1017&#x2013;1032. doi: 10.1038/s41591-020-0968-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z., Flammer A.J., Steiger P., Haberecker M., Andermatt R., Zinkernagel A.S., Mehra M.R., Schuepbach R.A., Ruschitzka F., Moch H. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417&#x2013;1418. doi: 10.1016/S0140-6736(20)30937-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kleine-Weber H., Schroeder S., Kr&#xfc;ger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.-H., Nitsche A., et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181:271&#x2013;280.e8. doi: 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons S., Fodil S., Azoulay E., Zafrani L. The vascular endothelium: The cornerstone of organ dysfunction in severe SARS-CoV-2 infection. Crit. Care. 2020;24:353. doi: 10.1186/s13054-020-03062-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03062-7</ArticleId><ArticleId IdType="pmc">PMC7296907</ArticleId><ArticleId IdType="pubmed">32546188</ArticleId></ArticleIdList></Reference><Reference><Citation>Okada H., Yoshida S., Hara A., Ogura S., Tomita H. Vascular endothelial injury exacerbates coronavirus disease 2019: The role of endothelial glycocalyx protection. Microcirculation. 2021;28:e12654. doi: 10.1111/micc.12654.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/micc.12654</ArticleId><ArticleId IdType="pmc">PMC7435519</ArticleId><ArticleId IdType="pubmed">32791568</ArticleId></ArticleIdList></Reference><Reference><Citation>Teuwen L.-A., Geldhof V., Pasut A., Carmeliet P. COVID-19: The vasculature unleashed. Nat. Rev. Immunol. 2020;20:389&#x2013;391. doi: 10.1038/s41577-020-0343-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0343-0</ArticleId><ArticleId IdType="pmc">PMC7240244</ArticleId><ArticleId IdType="pubmed">32439870</ArticleId></ArticleIdList></Reference><Reference><Citation>Chelazzi C., Villa G., Mancinelli P., de Gaudio A.R., Adembri C. Glycocalyx and sepsis-induced alterations in vascular permeability. Crit. Care. 2015;19:26. doi: 10.1186/s13054-015-0741-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-015-0741-z</ArticleId><ArticleId IdType="pmc">PMC4308932</ArticleId><ArticleId IdType="pubmed">25887223</ArticleId></ArticleIdList></Reference><Reference><Citation>Reitsma S., Slaaf D.W., Vink H., van Zandvoort M.A.M.J., oude Egbrink M.G.A. The endothelial glycocalyx: Composition, functions, and visualization. Pfl&#xfc;g. Arch. Eur. J. Physiol. 2007;454:345&#x2013;359. doi: 10.1007/s00424-007-0212-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00424-007-0212-8</ArticleId><ArticleId IdType="pmc">PMC1915585</ArticleId><ArticleId IdType="pubmed">17256154</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodcock T.E., Woodcock T.M. Revised Starling equation and the glycocalyx model of transvascular fluid exchange: An improved paradigm for prescribing intravenous fluid therapy. Br. J. Anaesth. 2012;108:384&#x2013;394. doi: 10.1093/bja/aer515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aer515</ArticleId><ArticleId IdType="pubmed">22290457</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraser D.D., Patterson E.K., Slessarev M., Gill S.E., Martin C., Daley M., Miller M.R., Patel M.A., Dos Santos C.C., Bosma K.J., et al. Endothelial Injury and Glycocalyx Degradation in Critically Ill Coronavirus Disease 2019 Patients: Implications for Microvascular Platelet Aggregation. Crit. Care Explor. 2020;2:e0194. doi: 10.1097/CCE.0000000000000194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCE.0000000000000194</ArticleId><ArticleId IdType="pmc">PMC7449254</ArticleId><ArticleId IdType="pubmed">32904031</ArticleId></ArticleIdList></Reference><Reference><Citation>Stahl K., Gronski P.A., Kiyan Y., Seeliger B., Bertram A., Pape T., Welte T., Hoeper M.M., Haller H., David S. Injury to the Endothelial Glycocalyx in Critically Ill Patients with COVID-19. Am. J. Respir. Crit. Care Med. 2020;202:1178&#x2013;1181. doi: 10.1164/rccm.202007-2676LE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202007-2676LE</ArticleId><ArticleId IdType="pmc">PMC7560808</ArticleId><ArticleId IdType="pubmed">32833500</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranieri V.M., Rubenfeld G.D., Thompson B.T., Ferguson N.D., Caldwell E., Fan E., Camporota L., Slutsky A.S. Acute respiratory distress syndrome: The Berlin Definition. JAMA. 2012;307:2526&#x2013;2533. doi: 10.1001/jama.2012.5669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2012.5669</ArticleId><ArticleId IdType="pubmed">22797452</ArticleId></ArticleIdList></Reference><Reference><Citation>Ando Y., Okada H., Takemura G., Suzuki K., Takada C., Tomita H., Zaikokuji R., Hotta Y., Miyazaki N., Yano H., et al. Brain-Specific Ultrastructure of Capillary Endothelial Glycocalyx and Its Possible Contribution for Blood Brain Barrier. Sci. Rep. 2018;8:17523. doi: 10.1038/s41598-018-35976-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-35976-2</ArticleId><ArticleId IdType="pmc">PMC6269538</ArticleId><ArticleId IdType="pubmed">30504908</ArticleId></ArticleIdList></Reference><Reference><Citation>Brauer R., Ge L., Schlesinger S.Y., Birkland T.P., Huang Y., Parimon T., Lee V., McKinney B.L., McGuire J.K., Parks W.C., et al. Syndecan-1 Attenuates Lung Injury during Influenza Infection by Potentiating c-Met Signaling to Suppress Epithelial Apoptosis. Am. J. Respir. Crit. Care Med. 2016;194:333&#x2013;344. doi: 10.1164/rccm.201509-1878OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201509-1878OC</ArticleId><ArticleId IdType="pmc">PMC4970595</ArticleId><ArticleId IdType="pubmed">26959387</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamaoka-Tojo M. Vascular Endothelial Glycocalyx Damage in COVID-19. Int. J. Mol. Sci. 2020;21:9712. doi: 10.3390/ijms21249712.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21249712</ArticleId><ArticleId IdType="pmc">PMC7766512</ArticleId><ArticleId IdType="pubmed">33352699</ArticleId></ArticleIdList></Reference><Reference><Citation>Tepasse P.-R., Vollenberg R., Fobker M., Kabar I., Schmidt H., Meier J.A., Nowacki T., H&#xfc;sing-Kabar A. Vitamin A Plasma Levels in COVID-19 Patients: A Prospective Multicenter Study and Hypothesis. Nutrients. 2021;13:2173. doi: 10.3390/nu13072173.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13072173</ArticleId><ArticleId IdType="pmc">PMC8308355</ArticleId><ArticleId IdType="pubmed">34202697</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Q., Meng M., Kumar R., Wu Y., Huang J., Deng Y., Weng Z., Yang L. Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis. Int. J. Infect. Dis. 2020;96:131&#x2013;135. doi: 10.1016/j.ijid.2020.04.086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.04.086</ArticleId><ArticleId IdType="pmc">PMC7196544</ArticleId><ArticleId IdType="pubmed">32376308</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J.J.Y., Lee K.S., Ang L.W., Leo Y.S., Young B.E. Risk Factors for Severe Disease and Efficacy of Treatment in Patients Infected With COVID-19: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis. Clin. Infect. Dis. 2020;71:2199&#x2013;2206. doi: 10.1093/cid/ciaa576.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa576</ArticleId><ArticleId IdType="pmc">PMC7239203</ArticleId><ArticleId IdType="pubmed">32407459</ArticleId></ArticleIdList></Reference><Reference><Citation>Karampoor S., Zahednasab H., Farahmand M., Mirzaei R., Zamani F., Tabibzadeh A., Bouzari B., Ajdarkosh H., Nikkhah M., Hashemi M.R., et al. A possible pathogenic role of Syndecan-1 in the pathogenesis of coronavirus disease 2019 (COVID-19) Int. Immunopharmacol. 2021;97:107684. doi: 10.1016/j.intimp.2021.107684.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.107684</ArticleId><ArticleId IdType="pmc">PMC8052477</ArticleId><ArticleId IdType="pubmed">33932696</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahrens T.D., Bang-Christensen S.R., J&#xf8;rgensen A.M., L&#xf8;ppke C., Spliid C.B., Sand N.T., Clausen T.M., Salanti A., Agerb&#xe6;k M.&#xd8;. The Role of Proteoglycans in Cancer Metastasis and Circulating Tumor Cell Analysis. Front. Cell Dev. Biol. 2020;8:749. doi: 10.3389/fcell.2020.00749.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2020.00749</ArticleId><ArticleId IdType="pmc">PMC7479181</ArticleId><ArticleId IdType="pubmed">32984308</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson A., Berkestedt I., Bodelsson M. Circulating glycosaminoglycan species in septic shock. Acta Anaesthesiol. Scand. 2014;58:36&#x2013;43. doi: 10.1111/aas.12223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.12223</ArticleId><ArticleId IdType="pubmed">24341693</ArticleId></ArticleIdList></Reference><Reference><Citation>Wadowski P.P., Kautzky-Willer A., Gremmel T., Koppensteiner R., Wolf P., Ertl S., Weikert C., Sch&#xf6;rgenhofer C., Jilma B. Sublingual microvasculature in diabetic patients. Microvasc. Res. 2020;129:103971. doi: 10.1016/j.mvr.2019.103971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mvr.2019.103971</ArticleId><ArticleId IdType="pubmed">31899168</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambrosino P., Calcaterra I., Molino A., Moretta P., Lupoli R., Spedicato G.A., Papa A., Motta A., Maniscalco M., Di Minno M.N.D. Persistent Endothelial Dysfunction in Post-Acute COVID-19 Syndrome: A Case-Control Study. Biomedicines. 2021;9:957. doi: 10.3390/biomedicines9080957.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9080957</ArticleId><ArticleId IdType="pmc">PMC8391623</ArticleId><ArticleId IdType="pubmed">34440161</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambrosino P., Molino A., Calcaterra I., Formisano R., Stufano S., Spedicato G.A., Motta A., Papa A., Di Minno M.N.D., Maniscalco M. Clinical Assessment of Endothelial Function in Convalescent COVID-19 Patients Undergoing Multidisciplinary Pulmonary Rehabilitation. Biomedicines. 2021;9:614. doi: 10.3390/biomedicines9060614.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9060614</ArticleId><ArticleId IdType="pmc">PMC8226503</ArticleId><ArticleId IdType="pubmed">34071308</ArticleId></ArticleIdList></Reference><Reference><Citation>Chioh F.W., Fong S.-W., Young B.E., Wu K.-X., Siau A., Krishnan S., Chan Y.-H., Carissimo G., Teo L.L., Gao F., et al. Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation. eLife. 2021;10:e64909. doi: 10.7554/eLife.64909.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.64909</ArticleId><ArticleId IdType="pmc">PMC7987341</ArticleId><ArticleId IdType="pubmed">33752798</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>